Ruth M. Pfeiffer

40.5k total citations · 5 hit papers
548 papers, 24.8k citations indexed

About

Ruth M. Pfeiffer is a scholar working on Oncology, Epidemiology and Cancer Research. According to data from OpenAlex, Ruth M. Pfeiffer has authored 548 papers receiving a total of 24.8k indexed citations (citations by other indexed papers that have themselves been cited), including 240 papers in Oncology, 95 papers in Epidemiology and 92 papers in Cancer Research. Recurrent topics in Ruth M. Pfeiffer's work include Viral-associated cancers and disorders (92 papers), Cancer Risks and Factors (75 papers) and Lymphoma Diagnosis and Treatment (45 papers). Ruth M. Pfeiffer is often cited by papers focused on Viral-associated cancers and disorders (92 papers), Cancer Risks and Factors (75 papers) and Lymphoma Diagnosis and Treatment (45 papers). Ruth M. Pfeiffer collaborates with scholars based in United States, United Kingdom and Canada. Ruth M. Pfeiffer's co-authors include Eric A. Engels, Meredith S. Shiels, Mitchell H. Gail, Annette M. Molinaro, Richard Simon, Ola Landgren, Anil K. Chaturvedi, William F. Anderson, Philip S. Rosenberg and Nicolas Wentzensen and has published in prestigious journals such as Science, New England Journal of Medicine and The Lancet.

In The Last Decade

Ruth M. Pfeiffer

530 papers receiving 24.3k citations

Hit Papers

Human Papillomavirus and ... 2005 2026 2012 2019 2011 2005 2009 2006 2011 500 1000 1.5k 2.0k 2.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States
    2011 2.7k citations Anil K. Chaturvedi, Eric A. Engels et al. profile →
  2. Prediction error estimation: a comparison of resampling methods
    2005 958 citations Ruth M. Pfeiffer et al. profile →
  3. Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study
    2009 743 citations Ola Landgren, Ruth M. Pfeiffer et al. Blood profile →
  4. Trends in cancer risk among people with AIDS in the United States 1980–2002
    2006 557 citations Eric A. Engels, Ruth M. Pfeiffer et al. profile →
  5. Cancer Burden in the HIV-Infected Population in the United States
    2011 540 citations Meredith S. Shiels, Ruth M. Pfeiffer et al. JNCI Journal of the National Cancer Institute profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ruth M. Pfeiffer United States 76 9.6k 5.1k 4.5k 4.3k 3.3k 548 24.8k
Philip S. Rosenberg United States 66 5.9k 0.6× 3.8k 0.7× 3.3k 0.7× 3.3k 0.8× 1.7k 0.5× 245 18.7k
Stephen M. Schwartz United States 95 4.7k 0.5× 9.3k 1.8× 4.6k 1.0× 6.2k 1.5× 2.0k 0.6× 407 30.5k
Brenda K. Edwards United States 51 12.4k 1.3× 3.6k 0.7× 3.8k 0.8× 3.8k 0.9× 2.8k 0.9× 95 25.4k
Lynn A. G. Ries United States 56 13.0k 1.4× 4.1k 0.8× 3.4k 0.7× 3.7k 0.8× 3.2k 1.0× 81 26.7k
William F. Anderson United States 55 8.9k 0.9× 3.6k 0.7× 3.0k 0.7× 4.6k 1.1× 2.6k 0.8× 134 21.6k
Steven Piantadosi United States 88 11.1k 1.2× 5.6k 1.1× 2.1k 0.5× 4.6k 1.1× 2.9k 0.9× 259 30.5k
Susan S. Devesa United States 90 11.5k 1.2× 5.4k 1.1× 4.2k 0.9× 7.8k 1.8× 4.8k 1.5× 205 30.5k
Benny Zee Hong Kong 73 9.8k 1.0× 2.6k 0.5× 3.5k 0.8× 6.0k 1.4× 1.9k 0.6× 324 23.2k
Julian Peto United Kingdom 63 8.2k 0.9× 5.6k 1.1× 12.5k 2.7× 7.5k 1.7× 3.5k 1.1× 158 34.8k
J.W.W. Coebergh Netherlands 87 16.3k 1.7× 3.9k 0.8× 4.2k 0.9× 5.3k 1.2× 4.2k 1.3× 520 30.6k

Countries citing papers authored by Ruth M. Pfeiffer

Since Specialization
Citations

This map shows the geographic impact of Ruth M. Pfeiffer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruth M. Pfeiffer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruth M. Pfeiffer more than expected).

Fields of papers citing papers by Ruth M. Pfeiffer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruth M. Pfeiffer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruth M. Pfeiffer. The network helps show where Ruth M. Pfeiffer may publish in the future.

Co-authorship network of co-authors of Ruth M. Pfeiffer

This figure shows the co-authorship network connecting the top 25 collaborators of Ruth M. Pfeiffer. A scholar is included among the top collaborators of Ruth M. Pfeiffer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruth M. Pfeiffer. Ruth M. Pfeiffer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pfeiffer, Ruth M., Isaac Brownell, Elizabeth K. Cahoon, et al.. (2024). Merkel Cell Carcinoma and Immunosuppression, UV Radiation, and Merkel Cell Polyomavirus. JAMA Dermatology. 161(1). 47–47. 1 indexed citations
2.
Abubakar, Mustapha, Maeve Mullooly, Sarah J. Nyante, et al.. (2022). Mammographic Density Decline, Tamoxifen Response, and Prognosis by Molecular Characteristics of Estrogen Receptor–Positive Breast Cancer. JNCI Cancer Spectrum. 6(3). 2 indexed citations
3.
Figueroa, Jonine D., Gretchen L. Gierach, Máire A. Duggan, et al.. (2021). Risk factors for breast cancer development by tumor characteristics among women with benign breast disease. Breast Cancer Research. 23(1). 34–34. 21 indexed citations
4.
D’Arcy, Monica, David Castenson, Charles F. Lynch, et al.. (2020). Risk of Rare Cancers Among Solid Organ Transplant Recipients. JNCI Journal of the National Cancer Institute. 113(2). 199–207. 23 indexed citations
5.
Liu, Zhiwei, Andriy Derkach, Kelly J. Yu, et al.. (2020). Patterns of Human Leukocyte Antigen Class I and Class II Associations and Cancer. Cancer Research. 81(4). 1148–1152. 16 indexed citations
6.
Zhou, Cindy Ke, Sarah E. Daugherty, Linda M. Liao, et al.. (2017). Do Aspirin and Other NSAIDs Confer a Survival Benefit in Men Diagnosed with Prostate Cancer? A Pooled Analysis of NIH-AARP and PLCO Cohorts. Cancer Prevention Research. 10(7). 410–420. 21 indexed citations
7.
Cook, Michael B., Frank Z. Stanczyk, Shannon N. Wood, et al.. (2017). Relationships between Circulating and Intraprostatic Sex Steroid Hormone Concentrations. Cancer Epidemiology Biomarkers & Prevention. 26(11). 1660–1666. 12 indexed citations
8.
Coghill, Anna E., Ruth M. Pfeiffer, Meredith S. Shiels, & Eric A. Engels. (2017). Excess Mortality among HIV-Infected Individuals with Cancer in the United States. Cancer Epidemiology Biomarkers & Prevention. 26(7). 1027–1033. 74 indexed citations
9.
Hofmann, Jonathan N., Brenda M. Birmann, Lauren R. Teras, et al.. (2016). Low Levels of Circulating Adiponectin Are Associated with Multiple Myeloma Risk in Overweight and Obese Individuals. Cancer Research. 76(7). 1935–1941. 27 indexed citations
10.
Lara, Pablo Espinosa, Ruth M. Pfeiffer, Zaida García‐Casado, et al.. (2015). Risk factors for keratinocyte skin cancer in patients diagnosed with melanoma, a large retrospective study. European Journal of Cancer. 53. 115–124. 15 indexed citations
11.
Drahos, Jennifer, Katrin Schwameis, Haiping Hao, et al.. (2015). MicroRNA Profiles of Barrett's Esophagus and Esophageal Adenocarcinoma: Differences in Glandular Non-native Epithelium. Cancer Epidemiology Biomarkers & Prevention. 25(3). 429–437. 31 indexed citations
12.
Nyante, Sarah J., Mark E. Sherman, Ruth M. Pfeiffer, et al.. (2015). Longitudinal Change in Mammographic Density among ER-Positive Breast Cancer Patients Using Tamoxifen. Cancer Epidemiology Biomarkers & Prevention. 25(1). 212–216. 20 indexed citations
13.
Pergoli, Laura, Chiara Favero, Ruth M. Pfeiffer, et al.. (2014). Blood DNA methylation, nevi number, and the risk of melanoma. Melanoma Research. 24(5). 480–487. 13 indexed citations
14.
Hyland, Paula L., L. Burke, Ruth M. Pfeiffer, et al.. (2014). Constitutional promoter methylation and risk of familial melanoma. Epigenetics. 9(5). 685–692. 11 indexed citations
15.
Khodr, Zeina G., Mark E. Sherman, Ruth M. Pfeiffer, et al.. (2014). Circulating Sex Hormones and Terminal Duct Lobular Unit Involution of the Normal Breast. Cancer Epidemiology Biomarkers & Prevention. 23(12). 2765–2773. 18 indexed citations
16.
Yang, Xiaohong R., Jonine D. Figueroa, Roni T. Falk, et al.. (2012). Analysis of terminal duct lobular unit involution in luminal A and basal breast cancers. Breast Cancer Research. 14(2). R64–R64. 36 indexed citations
17.
Shiels, Meredith S., Ruth M. Pfeiffer, Mitchell H. Gail, et al.. (2011). Cancer Burden in the HIV-Infected Population in the United States. JNCI Journal of the National Cancer Institute. 103(9). 753–762. 540 indexed citations breakdown →
18.
Kristinsson, Sigurður Y., Min Tang, Ruth M. Pfeiffer, et al.. (2010). Monoclonal gammopathy of undetermined significance and risk of skeletal fractures: a population-based study. Blood. 116(15). 2651–2655. 73 indexed citations
19.
Bolton, Kelly L., Montserrat García‐Closas, Ruth M. Pfeiffer, et al.. (2010). Assessment of Automated Image Analysis of Breast Cancer Tissue Microarrays for Epidemiologic Studies. Cancer Epidemiology Biomarkers & Prevention. 19(4). 992–999. 48 indexed citations
20.
Yang, Xiaohong R., Ruth M. Pfeiffer, Montserrat García‐Closas, et al.. (2007). Hormonal Markers in Breast Cancer: Coexpression, Relationship with Pathologic Characteristics, and Risk Factor Associations in a Population-Based Study. Cancer Research. 67(21). 10608–10617. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Philip S. Rosenberg Breakdown of academic impact, for papers by Stephen M. Schwartz Breakdown of academic impact, for papers by Brenda K. Edwards Breakdown of academic impact, for papers by Lynn A. G. Ries Breakdown of academic impact, for papers by William F. Anderson Breakdown of academic impact, for papers by Steven Piantadosi Breakdown of academic impact, for papers by Susan S. Devesa Breakdown of academic impact, for papers by Benny Zee Breakdown of academic impact, for papers by Julian Peto Breakdown of academic impact, for papers by J.W.W. Coebergh
Rankless by CCL
2026